(Alliance News) - Tate & Lyle PLC on Tuesday announced that its shareholders have voted in favour of its GBP2.7 billion acquisition by US peer Ingredion Inc. Read More
(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More
(Alliance News) - The FTSE 100 edged higher on Monday on a mixed day for stocks in London, as US markets recouped some of Friday's hefty falls and investors weighed another day of uncertainty in the Middle East. Read More
(Alliance News) - Stock prices in London were mixed at midday on Monday, as the FTSE 100 recovered from earlier losses, with investors rattled by renewed fighting between Israel and Iran and higher interest rate expectations. Read More
(Alliance News) - Stock prices in London opened lower on Monday, as investor confidence was hit by a fresh round of strikes between Israel and Iran. Read More
(Alliance News) - Tate & Lyle agrees to a GBP2.7 billion takeover by US rival Ingredion, boohoo and Revolution Beauty agree a new licensing partnership and Mpac expects profit to miss expectations. Read More
(Alliance News) - Tate & Lyle PLC on Thursday said its financial performance has been "disappointing" and said it is "acting with urgency" to return to top-line growth. Read More
(Alliance News) - Centrica will pay GBP20 million into Ofgem's redress fund and write off up to GBP70 million after the regulator closed its British Gas prepayment meter probe, while Unite Group says reservations for the next academic year remain in line with guidance. Building materials distributor Grafton sees revenue rise despite weaker trading in Great Britain. Read More
(Alliance News) - The FTSE 100 closed higher on Thursday as ongoing political uncertainty was offset by encouraging UK GDP data, a cooling oil price and easing gilt yields. Read More
